73 related articles for article (PubMed ID: 520386)
1. Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
Gross RJ; Eisdorfer CE; Schiller HS; Cox G
Exp Aging Res; 1979 Aug; 5(4):293-302. PubMed ID: 520386
[TBL] [Abstract][Full Text] [Related]
2. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
[TBL] [Abstract][Full Text] [Related]
3. Hydergine in senile mental impairment.
Loew DM; Weil C
Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
[TBL] [Abstract][Full Text] [Related]
4. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
5. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
Milvio C
Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
[TBL] [Abstract][Full Text] [Related]
6. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales.
Yesavage JA; Adey M
Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622
[No Abstract] [Full Text] [Related]
7. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
Lazzaroni M; Cattalini C; Massetto N; Poli A
Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
[TBL] [Abstract][Full Text] [Related]
8. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
9. Hydergine effect on prolactin and reaction time in dementia.
el Sobky A; el Shazly M; Darwish AK; Davies T; Griffin K; Keshavan MS
Biol Psychiatry; 1986 Oct; 21(12):1229-30. PubMed ID: 3756269
[No Abstract] [Full Text] [Related]
10. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
12. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
Aranda B; Dumoulin P; Groothold G
Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
[TBL] [Abstract][Full Text] [Related]
13. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
Görtelmeyer R; Erbler H
Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
[TBL] [Abstract][Full Text] [Related]
14. Review of clinical studies with ergots in gerontology.
Venn RD
Adv Biochem Psychopharmacol; 1980; 23():363-77. PubMed ID: 7395623
[No Abstract] [Full Text] [Related]
15. Factor structure of the Sandoz Clinical Assessment-Geriatric (SCAG) scale.
Hamot HB; Patin JR; Singer JM
Psychopharmacol Bull; 1984; 20(1):142-50. PubMed ID: 6718640
[No Abstract] [Full Text] [Related]
16. Lack of efficacy of hydergine in patients with Alzheimer's disease.
Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
[TBL] [Abstract][Full Text] [Related]
17. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
Hughes JR; Williams JG; Currier RD
J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
[TBL] [Abstract][Full Text] [Related]
18. Dihydroergocryptine in the management of senile psycho-organic syndrome.
Scarzella L; Bono G; Bergamasco B
Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
[TBL] [Abstract][Full Text] [Related]
19. Senile dementia: combined pharmacologic and psychologic treatment.
Yesavage JA; Westphal J; Rush L
J Am Geriatr Soc; 1981 Apr; 29(4):164-71. PubMed ID: 7204812
[TBL] [Abstract][Full Text] [Related]
20. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
